Attenuation of amyloid-β generation by atypical protein kinase C-mediated phosphorylation of engulfment adaptor PTB domain containing 1 threonine 35.
Adaptor Proteins, Signal Transducing
/ metabolism
Alzheimer Disease
/ metabolism
Amyloid beta-Peptides
/ metabolism
Amyloid beta-Protein Precursor
/ metabolism
Animals
CHO Cells
Cell Line, Tumor
Cricetulus
HEK293 Cells
Humans
Phosphorylation
Protein Binding
Protein Kinase C
/ metabolism
Protein Processing, Post-Translational
Threonine
/ metabolism
Alzheimer’s disease
GULP1
amyloid precursor protein
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
pubmed:
3
8
2019
medline:
9
6
2020
entrez:
3
8
2019
Statut:
ppublish
Résumé
Amyloid-β (Aβ) is derived from the proteolytic processing of amyloid precursor protein (APP), and the deposition of extracellular Aβ to form amyloid plaques is a pathologic hallmark of Alzheimer's disease (AD). Although reducing Aβ generation and accumulation has been proposed as a means of treating the disease, adverse side effects and unsatisfactory efficacy have been reported in several clinical trials that sought to lower Aβ levels. Engulfment adaptor phosphotyrosine-binding (PTB) domain containing 1 (GULP1) is a molecular adaptor that has been shown to interact with APP to alter Aβ production. Therefore, the modulation of the GULP1-APP interaction may be an alternative approach to reducing Aβ. However, the mechanisms that regulate GULP1-APP binding remain elusive. As GULP1 is a phosphoprotein, and because phosphorylation is a common mechanism that regulates protein interaction, we anticipated that GULP1 phosphorylation would influence GULP1-APP interaction and thereby Aβ production. We show here that the phosphorylation of GULP1 threonine 35 (T35) reduces GULP1-APP interaction and suppresses the stimulatory effect of GULP1 on APP processing. The residue is phosphorylated by an isoform of atypical PKC (PKCζ). Overexpression of PKCζ reduces both GULP1-APP interaction and GULP1-mediated Aβ generation. Moreover, the activation of PKCζ
Identifiants
pubmed: 31373844
doi: 10.1096/fj.201802825RR
pmc: PMC6902715
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
Amyloid beta-Peptides
0
Amyloid beta-Protein Precursor
0
GULP1 protein, human
0
Threonine
2ZD004190S
PKC-3 protein
EC 2.7.11.13
Protein Kinase C
EC 2.7.11.13
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
12019-12035Références
Brain Res Mol Brain Res. 2000 Oct 20;82(1-2):107-13
pubmed: 11042363
Electrophoresis. 1999 Dec;20(18):3551-67
pubmed: 10612281
J Biol Chem. 2008 Dec 19;283(51):35763-71
pubmed: 18845544
J Biol Chem. 2009 Oct 2;284(40):27480-6
pubmed: 19651783
Nature. 2013 Jan 17;493(7432):312-3
pubmed: 23283170
J Neurosci. 2012 Jul 11;32(28):9613-25
pubmed: 22787047
J Biol Chem. 2008 Oct 31;283(44):29621-5
pubmed: 18650431
F1000 Biol Rep. 2013;5:4
pubmed: 23413372
Diabetes. 2014 Dec;63(12):4291-301
pubmed: 25008180
J Neurochem. 2016 May;137(4):518-27
pubmed: 26865271
Proteomics. 2008 May;8(10):2024-34
pubmed: 18491316
J Neurosci. 2010 Dec 15;30(50):16983-92
pubmed: 21159968
Diabetes. 2003 Aug;52(8):1935-42
pubmed: 12882908
Neurology. 2008 Feb 5;70(6):440-8
pubmed: 17942819
Neurobiol Aging. 2012 Apr;33(4):732-43
pubmed: 20674096
Anal Chem. 2009 Sep 15;81(18):7778-87
pubmed: 19702290
J Neuropathol Exp Neurol. 2006 Apr;65(4):319-26
pubmed: 16691113
Mol Med. 1997 Mar;3(3):204-11
pubmed: 9100226
Neurosci Lett. 1998 Sep 18;254(1):29-32
pubmed: 9780084
J Biol Chem. 2003 Nov 21;278(47):47025-9
pubmed: 12970358
J Biol Chem. 2004 Apr 16;279(16):16161-9
pubmed: 14766758
J Biol Chem. 2004 Nov 19;279(47):49099-104
pubmed: 15347685
Biochem Pharmacol. 1996 Apr 26;51(8):1089-93
pubmed: 8866831
J Neurosci Res. 2004 Jan 1;75(1):12-24
pubmed: 14689444
J Alzheimers Dis. 2009;18(2):253-65
pubmed: 19584434
Biochem J. 2011 Jun 15;436(3):631-9
pubmed: 21486224
PLoS One. 2009;4(2):e4647
pubmed: 19247477
Cold Spring Harb Perspect Biol. 2013 Dec 01;5(12):a008987
pubmed: 24296166
J Gerontol A Biol Sci Med Sci. 2016 Jan;71(1):30-9
pubmed: 25659889
J Biol Chem. 2001 Mar 30;276(13):10025-31
pubmed: 11104762
Neurobiol Dis. 2009 Oct;36(1):162-8
pubmed: 19631749
EMBO J. 2013 May 15;32(10):1365-80
pubmed: 23511975
J Proteome Res. 2008 Mar;7(3):1346-51
pubmed: 18220336
Front Mol Neurosci. 2017 Sep 15;10:294
pubmed: 28966576
Brain Res. 2006 Nov 13;1119(1):1-12
pubmed: 17007823
J Biol Chem. 2008 Dec 12;283(50):34728-37
pubmed: 18922798
Biol Psychiatry. 2010 Mar 15;67(6):505-12
pubmed: 19358976
J Mol Biol. 2016 Apr 10;428(7):1455-64
pubmed: 26992354
J Mol Biol. 2005 Jan 7;345(1):1-20
pubmed: 15567406
Mol Cell Neurosci. 2002 May;20(1):13-20
pubmed: 12056836
J Cell Biol. 2003 Oct 13;163(1):83-95
pubmed: 14557249
Biochem J. 2004 Feb 15;378(Pt 1):83-92
pubmed: 14580237
Nat Methods. 2007 Nov;4(11):923-5
pubmed: 17952086
J Biol Chem. 1997 Jan 24;272(4):2551-8
pubmed: 8999972
J Neurosci. 2009 Apr 8;29(14):4442-60
pubmed: 19357271
Biochem Pharmacol. 2011 Sep 1;82(5):505-13
pubmed: 21645497
Mol Cell Proteomics. 2014 Jul;13(7):1690-704
pubmed: 24719451
Hum Mutat. 1998;11(6):481
pubmed: 10200054
J Neurochem. 2005 Apr;93(2):330-8
pubmed: 15816856
EMBO J. 1997 Oct 15;16(20):6141-50
pubmed: 9321393
N Engl J Med. 2014 Jan 23;370(4):311-21
pubmed: 24450890
J Biol Chem. 2006 Apr 28;281(17):12081-92
pubmed: 16497666
Cancer Res. 2009 Mar 15;69(6):2663-8
pubmed: 19276368
Neuro Endocrinol Lett. 2014;35(3):224-9
pubmed: 24977973
J Biol Chem. 1995 Oct 6;270(40):23243-5
pubmed: 7559474
BMC Neurosci. 2010 Feb 10;11:18
pubmed: 20146799
J Biol Chem. 2018 May 18;293(20):7674-7688
pubmed: 29615491
J Proteome Res. 2011 Dec 2;10(12):5354-62
pubmed: 22073976
Brain Res Bull. 2002 Feb-Mar 1;57(3-4):481-3
pubmed: 11923014
Prog Neurobiol. 2017 Sep;156:189-213
pubmed: 28587768
Diabetes. 2003 Aug;52(8):1926-34
pubmed: 12882907
Ann Neurol. 2011 Feb;69(2):237-9
pubmed: 21387368
J Biol Chem. 1999 Sep 3;274(36):25308-16
pubmed: 10464256
Metabolism. 2012 Apr;61(4):459-69
pubmed: 22225955
Pharmacol Res. 2010 Oct;62(4):308-17
pubmed: 20561999
J Biol Chem. 2003 Mar 14;278(11):9290-7
pubmed: 12645527
Biochemistry. 2001 Jan 9;40(1):249-55
pubmed: 11141077
J Neurosci. 2008 Dec 31;28(53):14392-400
pubmed: 19118172
Mol Cell Neurosci. 2000 Nov;16(5):557-65
pubmed: 11083918
J Alzheimers Dis. 2008 Apr;13(3):323-31
pubmed: 18430999
EMBO J. 2013 May 15;32(10):1348-9
pubmed: 23563118
J Biol Chem. 2013 Mar 29;288(13):9438-46
pubmed: 23396968
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Mol Cell Biol. 1996 Nov;16(11):6229-41
pubmed: 8887653
Neurobiol Dis. 2009 Mar;33(3):518-25
pubmed: 19166938
Cell Stem Cell. 2012 Jul 6;11(1):23-35
pubmed: 22770240
Biochem J. 2015 Sep 15;470(3):303-17
pubmed: 26188042
J Neurosci. 2007 Mar 28;27(13):3439-44
pubmed: 17392460
Nat Rev Neurol. 2018 Mar;14(3):168-181
pubmed: 29377010
FEBS Lett. 2002 Feb 20;513(1):67-70
pubmed: 11911882
J Biol Chem. 2006 Dec 8;281(49):37853-60
pubmed: 17032642
PLoS One. 2012;7(3):e32792
pubmed: 22403710
Physiol Genomics. 2008 Apr 22;33(2):240-56
pubmed: 18270320
J Biol Chem. 2003 Sep 19;278(38):36572-81
pubmed: 12826668
Neurology. 2003 Jun 24;60(12):1899-903
pubmed: 12821730
EMBO J. 2006 Jan 25;25(2):420-31
pubmed: 16407979
Cold Spring Harb Perspect Med. 2012 May;2(5):a006270
pubmed: 22553493
Brain Res Bull. 2016 Mar;121:178-85
pubmed: 26861514
Mol Cell Biol. 2013 Mar;33(5):874-86
pubmed: 23249950
J Alzheimers Dis. 2018;61(2):673-688
pubmed: 29254083
EMBO Rep. 2008 Nov;9(11):1134-40
pubmed: 18833287
Biochemistry. 2009 May 5;48(17):3787-94
pubmed: 19236051
Biochem J. 2002 Jan 15;361(Pt 2):355-61
pubmed: 11772407
Sci Rep. 2017 Sep 29;7(1):12456
pubmed: 28963516
J Biol Chem. 1997 Nov 28;272(48):30075-82
pubmed: 9374484